Rabeprazole Dosing for GERD and Peptic Ulcers

Standard Dosing Recommendations

The American Gastroenterological Association notes that most clinical trials on PPIs used once-daily dosing, even though the pharmacodynamics logically supports twice-daily dosing 3
Rabeprazole should be taken 30-60 minutes before meals for optimal efficacy 1

Twice-daily PPI dosing may be considered for patients who have not responded adequately to once-daily therapy after 4-8 weeks of treatment 1
For patients with extraesophageal GERD syndromes who also have typical GERD symptoms, twice-daily PPI dosing for 2-3 months may be considered as empiric therapy 2
Patients with severe erosive esophagitis who fail to respond to standard once-daily dosing may benefit from twice-daily dosing 3
Expert opinion generally recommends twice-daily dosing of PPIs to improve symptom relief in patients with an esophageal GERD syndrome with an unsatisfactory response to once-daily dosing 3

The American Gastroenterological Association recommends that after initial symptom control, patients should be considered for step-down to the lowest effective dose 1
Long-term PPI use has been associated with potential concerns including increased risk of community-acquired pneumonia, enterochromaffin cell hyperplasia, and potential associations with gastroenteritis and candidemia 1
All patients on long-term PPI therapy should have their need for continued treatment periodically reassessed 1
If symptoms persist after 4-8 weeks, consider increasing to twice-daily dosing 1, 3
Potassium-competitive acid blockers are emerging as alternatives to PPIs for patients who fail twice-daily PPI therapy 4, 5